Unfortune Poor celebs…when will they learn?

31Mar/08

Cholesterol DrugsTake a Fall

The marketing of Vytorin and Zetia raced ahead of the science. Now Schering and Merck shareholders are $22 billion poorer

Comments (0) Trackbacks (0)

No comments yet.


Leave a comment

No trackbacks yet.